What Is Compulsory Licensing?
Compulsory licensing is a legal mechanism that allows a government to authorise the use of a patented invention without the patent holder's consent, typically to address public health emergencies, national security needs, or anti-competitive behaviour.
Under a compulsory licence, a government grants permission to a third party — or itself — to produce, use, or sell a patented product without the patent owner's agreement. The patent holder still receives royalty payments, but loses the ability to control who uses their invention. Compulsory licensing is enshrined in the TRIPS Agreement (Article 31) administered by the World Trade Organization. It is most commonly invoked for pharmaceuticals during public health crises, but can apply to any patented technology. Countries must follow specific procedural requirements: the applicant must first attempt to negotiate a voluntary licence on reasonable commercial terms, the scope and duration must be limited, and adequate remuneration must be paid to the patent holder.
Why It Matters
For patent holders, compulsory licensing represents a ceiling on the exclusivity that patents provide. Even with a granted patent, there is no guarantee of absolute market control — governments retain the power to intervene when the public interest demands it. For businesses building an IP strategy, understanding compulsory licensing risk is essential. Industries like pharmaceuticals, clean energy, and essential technologies face higher exposure. This risk factor should inform decisions about whether to rely solely on patents or to supplement with trade secret protection. From a policy perspective, compulsory licensing balances private IP rights against public welfare. It ensures that critical innovations — life-saving medicines, essential infrastructure technologies — remain accessible when market mechanisms fail.
How This Connects to IP Protection
Compulsory licensing only applies to patents, not to trade secrets. When companies protect innovations as trade secrets rather than patents, they avoid compulsory licensing risk entirely — no government can force disclosure of something that was never publicly registered. immut helps businesses document and timestamp trade secrets on the blockchain, creating verifiable proof of ownership without the public disclosure that patents require. For innovations where compulsory licensing is a concern, this approach preserves both confidentiality and legal protection. By maintaining blockchain-verified records of when trade secrets were created, companies also establish a strong foundation for defending their rights in disputes — without ever triggering the government override mechanisms that apply to patents.
Common Mistakes to Avoid
Assuming patents are absolute: Many companies believe a granted patent guarantees exclusive rights in all circumstances. Compulsory licensing demonstrates that government intervention can override this exclusivity when public interest demands it.
Ignoring jurisdiction-specific rules: Compulsory licensing provisions vary significantly by country. What triggers a licence in India differs from the UK or US. Companies operating internationally must understand local laws.
Failing to consider alternatives: Companies often default to patent protection without assessing whether trade secrets might offer stronger, more durable protection for certain innovations — especially those vulnerable to compulsory licensing.
Neglecting negotiation requirements: Most jurisdictions require good-faith negotiation before a compulsory licence is granted. Companies that refuse reasonable licensing terms may inadvertently invite government intervention.
Frequently Asked Questions
When can a government issue a compulsory licence?
Governments can issue compulsory licences during national emergencies, for public non-commercial use, to remedy anti-competitive practices, or when a patent holder has failed to work the patent domestically. The specific grounds vary by jurisdiction but are governed internationally by the TRIPS Agreement.
Does the patent holder receive any compensation under compulsory licensing?
Yes. Under the TRIPS Agreement, patent holders must receive adequate remuneration — typically royalty payments that reflect the economic value of the licence. The exact amount is often determined by courts or regulatory bodies and varies case by case.
Can trade secrets be subject to compulsory licensing?
No. Compulsory licensing only applies to registered patents. Trade secrets, by definition, are not publicly registered and therefore cannot be compulsorily licensed. This is one reason some companies prefer trade secret protection for certain innovations.
Protect Your Intellectual Property Today
Whether you are navigating compulsory licensing or building a broader IP strategy, immut gives you instant blockchain-verified proof of your innovations — no lawyers, no delays.